Her research interests lie in vaccine development and investigating rapid diagnostic tests for meningitis and septicaemia.
Dr Xilian Bai
Professional expert
Xilian graduated in medicine from China Medical University before specialising in paediatric/neonatal intensive care and paediatric infectious diseases.
From the Vaccine Evaluation Unit, Public Health England, Manchester, Xilian gained her PhD in 2005 at the University of Manchester before joining the Vaccine Evaluation Unit at Public Health England in 2008, where she is responsible for the evaluation of meningococcal vaccines. Her research interests lie in vaccine development and investigating rapid diagnostic tests for meningitis and septicaemia.
Recently published articles
- The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations
- Evaluation of strain coverage of the multicomponent meningococcal serogroup B vaccine (4CMenB) administered in infants according to different immunisation schedules
- Quality, immunogenicity and stability of meningococcal serogroup ACWY-CRM 197, DT and TT glycoconjugate vaccines
- Immunogenicity of a meningococcal B vaccine during a university outbreak
